BFM
HZNP

Boothbay Fund Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Boothbay Fund Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-69,911
Closed -$8.09M – 2141
2023
Q3 		$8.09M Buy
69,911
+66,551
+1,981% +$7.15M 0.19% 104
2023
Q2 		$346K Sell
3,360
-81,915
-96% -$8.64M 0.01% 1251
2023
Q1 		$9.31M Sell
85,275
-6,967
-8% -$770K 0.19% 93
2022
Q4 		$10.5M Buy
92,242
+9,854
+12% +$818K 0.24% 61
2022
Q3 		$5.1M Buy
82,388
+14,701
+22% +$1.03M 0.13% 186
2022
Q2 		$5.4M Buy
67,687
+5,356
+9% +$507K 0.14% 158
2022
Q1 		$6.56M Buy
62,331
+14,608
+31% +$1.42M 0.15% 135
2021
Q4 		$5.14M Buy
47,723
+38,477
+416% +$4.2M 0.12% 187
2021
Q3 		$1.01M Sell
9,246
-6,965
-43% -$723K 0.03% 750
2021
Q2 		$1.52M Buy
16,211
+11,557
+248% +$1.06M 0.05% 511
2021
Q1 		$428K Sell
4,654
-15,150
-76% -$1.28M 0.02% 1017
2020
Q4 		$1.45M Buy
+19,804
New +$1.47M 0.05% 361
2019
Q2 		– Sell
-36,227
Closed -$957K – 998
2019
Q1 		$957K Buy
36,227
+6,227
+21% +$148K 0.09% 240
2018
Q4 		$586K Buy
+30,000
New +$588K 0.09% 236

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boothbay Fund Management's HZNP Position: Q4 2023 in Review

Boothbay Fund Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 69,911 shares — an estimated $8.09M sold.

Boothbay Fund Management first reported a position in HZNP in Q4 2018 and held it in 14 quarters. The position peaked at $10.5M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Boothbay Fund Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 69,911 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $8.09M.
  • Boothbay Fund Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 14 quarters.
  • Boothbay Fund Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.5M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Boothbay Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.